Tango Therapeutics director granted stock, options
Tango Therapeutics director Lesley Ann Calhoun received new equity awards, increasing her direct stake in the company.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Tango Therapeutics director Lesley Ann Calhoun received new equity awards, increasing her direct stake in the company. She was granted 4,000 shares of Common Stock in the form of restricted stock units and now directly holds 16,500 Common shares after this award.
She was also granted options to purchase 25,000 shares of Common Stock at an exercise price of $20.2200 per share, expiring on June 5, 2036. The RSUs vest in full on the earlier of June 5, 2027 or the next annual stockholder meeting, while the options vest in 12 equal monthly installments starting July 5, 2026, in each case subject to her continuous service.
Insider Trade Summary
Grant/Award: 29,000 shares
Grant/Award
2 txns
Insider
Calhoun Lesley Ann
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 25,000 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 4,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 25,000 contracts (Direct);
Common Stock — 16,500 shares (Direct)
Footnotes (2)
- F1. These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027 and (ii) the date of the next annual meeting of stockholders, in each case subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
- F2. This option shall vest and become exercisable in 12 substantially equal monthly installments over a period of one year, with the first vesting date on July 5, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
Key Figures
RSU grant: 4,000 shares
Shares held after grant: 16,500 shares
Option grant size: 25,000 options
+4 more
7 metrics
RSU grant
4,000 shares
Restricted stock units granted June 5, 2026
Shares held after grant
16,500 shares
Common Stock directly owned after RSU award
Option grant size
25,000 options
Stock Option (Right to Buy) granted June 5, 2026
Option exercise price
$20.2200 per share
Strike price for 25,000 stock options
Option expiration
June 5, 2036
Expiration date of stock options
RSU vesting date
Earlier of June 5, 2027 or next AGM
Full vesting timing for 4,000 RSUs
Option vesting start
July 5, 2026
First of 12 monthly vesting installments
Key Terms
restricted stock units, RSUs, Stock Option (Right to Buy), vest, +1 more
5 terms
restricted stock units financial
"These shares are represented by restricted stock units (the "RSUs")."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"Each RSU represents a contingent right to receive one share of Common Stock."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
Stock Option (Right to Buy) financial
"Stock Option (Right to Buy)"
vest financial
"The RSUs will vest in their entirety on the earlier of: (i) June 5, 2027..."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
continuous service financial
"subject to the Reporting Person's continuous service with the Issuer as of each such vesting date."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Tango Therapeutics (TNGX) director Lesley Ann Calhoun receive?
Lesley Ann Calhoun received 4,000 restricted stock units and options for 25,000 shares of Tango Therapeutics Common Stock. The options have a $20.2200 exercise price and expire on June 5, 2036, forming part of her director compensation.
How do the new RSUs for Tango Therapeutics (TNGX) director vest?
The 4,000 RSUs granted to director Lesley Ann Calhoun vest in full on the earlier of June 5, 2027 or the next annual stockholder meeting. Vesting is contingent on her continuous service with Tango Therapeutics through the applicable vesting date.
What is the vesting schedule for Lesley Ann Calhoun’s Tango Therapeutics stock options?
The 25,000 Tango Therapeutics stock options vest and become exercisable in 12 substantially equal monthly installments over one year. The first vesting date is July 5, 2026, and each installment requires Lesley Ann Calhoun to remain in continuous service with the company.
What is the exercise price and expiration date of the new Tango Therapeutics options?
Lesley Ann Calhoun’s newly granted Tango Therapeutics stock options have a $20.2200 per share exercise price. These options expire on June 5, 2036, providing a long-dated opportunity to purchase Common Stock if vesting conditions and exercise are satisfied.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates